COAGADEX

This brand name is authorized in Austria, Estonia, Ireland, Lithuania, Poland, United Kingdom

Active ingredients

The drug COAGADEX contains one active pharmaceutical ingredient (API):

1 Coagulation factor X
UNII 0P94UQE6SY - COAGULATION FACTOR X HUMAN

Coagulation factor X is derived from human plasma and used as a replacement for the naturally existing coagulation factor X in patients with hereditary factor X deficiency.

Read about Coagulation factor X

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
COAGADEX Powder and solvent for solution for injection European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
B02BD13 B Blood and blood forming organs → B02 Antihemorrhagics → B02B Vitamin K and other hemostatics → B02BD Blood coagulation factors
Discover more medicines within B02BD13

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1713776, 1713787
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 327525, 360753
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1079856, 1079857
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100367737, 100367743

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.